Mizrachi Yossi, Tannus Samer, Bar Jacob, Sagiv Ron, Levy Tally, Condrea Alexander, Ginath Shimon
Department of Obstetrics and Gynecology, Wolfson Medical Center, Holon, affiliated with Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Isr Med Assoc J. 2017 Oct;19(10):631-634.
Several studies have addressed the issue of undetected uterine pathology in women undergoing hysterectomy for pelvic organ prolapse (POP). However, these studies differ largely with respect to the incidence of malignancy found, study population, and preoperative evaluation.
To assess the risk of unexpected pre-malignant and malignant uterine pathological findings after vaginal hysterectomy for POP repair, in a single medical center in Israel.
A retrospective study was performed of all patients who underwent vaginal hysterectomy due to symptomatic POP between January 1990 and April 2015 in a single tertiary medical center. Selected clinical and pathological data were retrieved from the computerized medical records. All specimens were routinely sent for histopathological assessment. All women were managed according to a uniform protocol that required the presence of a preoperative normal Pap smear, and included preoperative transvaginal sonography and endometrial biopsy when indicated. Patients in whom premalignant or malignant lesions were found preoperatively were not included in the study.
The study comprised 667 patients. The overall rate of malignant or significant premalignant pathologies (6 cases) was 0.89%, including one (0.14%) case of endometrial carcinoma. All premalignant and malignant pathologies were found only in post-menopausal patients. The rate of significant endometrial pathological lesions found in asymptomatic post-menopausal women was only 0.35%.
The rate of preoperatively undetected abnormal histopathological findings in patients who undergo vaginal hysterectomy due to POP is very low, and therefore more extensive preoperative evaluation is not warranted in them.
多项研究探讨了因盆腔器官脱垂(POP)而行子宫切除术的女性未被发现的子宫病变问题。然而,这些研究在发现的恶性肿瘤发生率、研究人群和术前评估方面存在很大差异。
评估在以色列的一个单一医疗中心,因POP修复而行阴道子宫切除术后意外发现癌前和恶性子宫病理结果的风险。
对1990年1月至2015年4月期间在一个单一的三级医疗中心因有症状的POP而行阴道子宫切除术的所有患者进行回顾性研究。从计算机化医疗记录中检索选定的临床和病理数据。所有标本均常规送检进行组织病理学评估。所有女性均按照统一方案进行管理,该方案要求术前巴氏涂片正常,必要时包括术前经阴道超声检查和子宫内膜活检。术前发现癌前或恶性病变的患者不纳入本研究。
该研究包括667例患者。恶性或显著癌前病变的总体发生率(6例)为0.89%,其中子宫内膜癌1例(0.14%)。所有癌前和恶性病变仅在绝经后患者中发现。无症状绝经后女性中发现的显著子宫内膜病理病变率仅为0.35%。
因POP而行阴道子宫切除术的患者术前未被发现的异常组织病理学结果发生率非常低,因此无需对其进行更广泛的术前评估。